L’EFSA pubblica tutta la sua produzione scientifica, compresi i pareri scientifici, nell’EFSA Journal. Divulga inoltre una serie di pubblicazioni di supporto. Vedi anche: Definizione atti scientifici e pubblicazioni di supporto.
The GMO Panel has previously assessed genetically modified (GM) soybean A2704‐12. This soybean was found to be as safe and nutritious as its conventional counterpart with respect to potential effects on human and animal health and the environment in the c ...
The GMO Panel has previously assessed genetically modified (GM) soybean BPS‐CV127‐9. This soybean was found to be as safe and nutritious as its conventional counterpart and commercial soybean varieties with respect to potential effects on human and animal ...
The GMO Panel has previously assessed genetically modified (GM) carnation FLO‐40689‐6 and concluded that there is no scientific reason to consider that the import, distribution and retailing in the EU of carnation FLO‐40689‐6 cut flowers for ornamental us ...
According to Article 12(1) of Regulation (EC) No 396/2005, EFSA shall provide within 12 months from the date of the inclusion or non-inclusion of an active substance in Annex I to Directive 91/414/EEC a reasoned opinion on the review of the existing maxim ...
According to Article 5(1) of Regulation (EC) No 396/2005, active substances of plant protection products evaluated under Directive 91/414/EEC for which no maximum residue levels (MRLs) are required shall be defined and listed in Annex IV to this Regulatio ...
The GMO Panel has previously assessed genetically modified (GM) soybean 305423 as a single event and as part of a two-event stack, 305423 × 40-3-2. These soybean events were found to be as safe as their conventional counterparts and other appropriate comp ...
The GMO Panel has previously assessed genetically modified (GM) soybean 40-3-2 as a single event and as part of a two-event stack, 305423 × 40-3-2. These soybean events were found to be as safe as their conventional counterparts and other appropriate comp ...
The European Commission mandated EFSA to review a new data package provided by the company Elanco, for the possible integration/non-integration of the DNA plasmid vaccine CLYNAV into the genome of Atlantic salmon (Salmo salar) and to indicate whether EFSA ...
EFSA was requested to provide a scientific assessment of additional information submitted to demonstrate whether the active substance pymetrozine can be used such that exposure to humans may be considered negligible. The context of the assessment was that ...
According to Article 5(1) of Regulation (EC) No 396/2005, active substances of plant protection products evaluated under Directive 91/414/EEC for which no MRLs are required shall be defined and listed in Annex IV to this Regulation. Among the active subst ...